While mounting evidence has documented the importance of both UCP2 and UCP3 variability in the pathophysiology of different chronic metabolic diseases, such as diabetes and obesity [41], [56], relatively little is known of their implication in human aging and longevity. The gene discussed is UCP2; the disease is obesity disorder.